281 related articles for article (PubMed ID: 29445059)
21. Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease.
Sagawa T; Kogiso T; Sugiyama H; Hashimoto E; Yamamoto M; Tokushige K
Hepatol Res; 2020 Jul; 50(7):853-862. PubMed ID: 32219953
[TBL] [Abstract][Full Text] [Related]
22. Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation.
Nii M; Inuzuka R; Inai K; Shimada E; Shinohara T; Kogiso T; Ono H; Ootsuki S; Kurita Y; Takeda A; Hirono K; Takei K; Yasukochi S; Yoshikawa T; Furutani Y; Shinozaki T; Matsuyama Y; Senzaki H; Tokushige K; Nakanishi T
Circulation; 2021 Dec; 144(25):2043-2045. PubMed ID: 34928702
[No Abstract] [Full Text] [Related]
23. HEPATOCELLULAR CARCINOMA WITH CARDIAC CIRRHOSIS AFTER THE FONTAN PROCEDURE.
Suna N; Özer Etik D; Öcal S; Hilmioğlu F
Gastroenterol Nurs; 2018; 41(1):68-71. PubMed ID: 29373356
[No Abstract] [Full Text] [Related]
24. Hepatocellular carcinoma in the adult Fontan patient.
Conroy MR; Moe TG
Cardiol Young; 2017 Mar; 27(2):407-409. PubMed ID: 27640301
[TBL] [Abstract][Full Text] [Related]
25. Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease.
Suzuki H; Niizeki T; Shirono T; Koteda Y; Kinjyo Y; Mizukami N; Koda M; Ota S; Nakano M; Okamura S; Iwamoto H; Shimose S; Noda Y; Kamachi N; Kajiwara A; Suda K; Akiba J; Yano H; Kuromatsu R; Koga H; Torimura T
Intern Med; 2022 Apr; 61(8):1145-1150. PubMed ID: 34565776
[TBL] [Abstract][Full Text] [Related]
26. Incidence, Predictors, and Mortality in Patients With Liver Cancer After Fontan Operation.
Ohuchi H; Hayama Y; Nakajima K; Kurosaki K; Shiraishi I; Nakai M
J Am Heart Assoc; 2021 Feb; 10(4):e016617. PubMed ID: 33538186
[TBL] [Abstract][Full Text] [Related]
27. Challenges in Accurate Diagnosis of HCC in FALD: A Case Series.
Feeley M; Hopkins K; Grinspan LT; Schiano T; Love B; Chan A; Lewis S; Zaidi AN
Pediatr Cardiol; 2023 Oct; 44(7):1447-1453. PubMed ID: 37318608
[TBL] [Abstract][Full Text] [Related]
28. Liver disease secondary to congenital heart disease in children.
Komatsu H; Inui A; Kishiki K; Kawai H; Yoshio S; Osawa Y; Kanto T; Fujisawa T
Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):651-666. PubMed ID: 31131680
[No Abstract] [Full Text] [Related]
29. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma.
Ghaferi AA; Hutchins GM
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1348-52. PubMed ID: 15942576
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
31. [Fontan-associated liver disease current status and transplantation consideration].
Liu X; Tu JZC; Teng Y; Chen JM
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):109-112. PubMed ID: 36948859
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma in two patients with cardiac cirrhosis.
Saliba T; Dorkhom S; O'Reilly EM; Ludwig E; Gansukh B; Abou-Alfa GK
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):889-91. PubMed ID: 19550346
[TBL] [Abstract][Full Text] [Related]
33. High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis.
Miyakawa K; Tarao K; Ohshige K; Morinaga S; Ohkawa S; Okamoto N; Shibuya A; Adachi S; Miura Y; Fujiyama S; Miyase S; Tomita K
Scand J Gastroenterol; 2009; 44(11):1340-8. PubMed ID: 19891585
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
Emamaullee J; Martin S; Goldbeck C; Rocque B; Barbetta A; Kohli R; Starnes V
Ann Surg; 2022 Sep; 276(3):482-490. PubMed ID: 35766375
[TBL] [Abstract][Full Text] [Related]
35. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
36. Etiology of liver cirrhosis in Japan: a nationwide survey.
Michitaka K; Nishiguchi S; Aoyagi Y; Hiasa Y; Tokumoto Y; Onji M;
J Gastroenterol; 2010; 45(1):86-94. PubMed ID: 19789837
[TBL] [Abstract][Full Text] [Related]
37. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors.
Baek JS; Bae EJ; Ko JS; Kim GB; Kwon BS; Lee SY; Noh CI; Park EA; Lee W
Heart; 2010 Nov; 96(21):1750-5. PubMed ID: 20956491
[TBL] [Abstract][Full Text] [Related]
38. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
Schleiger A; Salzmann M; Kramer P; Danne F; Schubert S; Bassir C; Müller T; Müller HP; Berger F; Ovroutski S
Pediatr Cardiol; 2020 Apr; 41(4):736-746. PubMed ID: 32006084
[TBL] [Abstract][Full Text] [Related]
39. Abdominal Imaging Surveillance in Adult Patients After Fontan Procedure: Risk of Chronic Liver Disease and Hepatocellular Carcinoma.
Nandwana SB; Olaiya B; Cox K; Sahu A; Mittal P
Curr Probl Diagn Radiol; 2018; 47(1):19-22. PubMed ID: 28602501
[TBL] [Abstract][Full Text] [Related]
40. Elevated non-invasive liver fibrosis markers and risk of liver carcinoma in adult patients after repair of tetralogy of Fallot.
Yamamura K; Sakamoto I; Morihana E; Hirata Y; Nagata H; Yamasaki Y; Okumura Y; Kohashi K; Koto K; Tsutsui H; Ohga S
Int J Cardiol; 2019 Jul; 287():121-126. PubMed ID: 31006598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
